Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Biogen Inc (BIIB)

Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease PR Newswire - Fri May 8, 1:30AM CDT

TOKYO and CAMBRIDGE, Mass. , May 8, 2026 /PRNewswire/ -- Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period...

BIIB : 193.45 (+1.08%)
GTM
3 Value Stocks We Approach with Caution StockStory - Thu May 7, 11:36PM CDT

3 Value Stocks We Approach with Caution

GTM : 6.38 (-3.77%)
LEVI : 22.67 (-0.35%)
BIIB : 193.45 (+1.08%)
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire - Thu May 7, 5:01PM CDT

NEW YORK , May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14:

RELY : 24.03 (+5.44%)
APLS : 41.03 (+0.05%)
SPGI : 420.12 (-2.00%)
TPH : 46.95 (unch)
BIIB : 193.45 (+1.08%)
BFAM : 70.59 (+3.34%)
Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates Business Wire - Thu May 7, 3:01PM CDT

– New 4-year longitudinal data from the Phase 1/2a open-label extension (OLE) studies provide additional support for the disease-modifying potential of zorevunersen, an investigational medicine for the...

STOK : 32.89 (+0.30%)
BIIB : 193.45 (+1.08%)
Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates Business Wire - Thu Apr 30, 3:01PM CDT

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational...

STOK : 32.89 (+0.30%)
BIIB : 193.45 (+1.08%)
BIIB
Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales StockStory - Wed Apr 29, 5:25AM CDT

Biogen (NASDAQ:BIIB) Surprises With Q1 CY2026 Sales

BIIB : 193.45 (+1.08%)
Biogen's Turnaround Thesis Hangs on Whether New Products Can Offset the MS Decline Barchart - Tue Apr 28, 4:05PM CDT

Barchart Research What to Expect from BIIB Earnings BIIB Generated April 28, 2026 Current Price $183.38 EPS Estimate $$2.96 Consensus Rating Moderate Buy Average Move 2.80% Biogen's Turnaround Thesis Hangs...

BIIB : 193.45 (+1.08%)
BIIB
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect StockStory - Mon Apr 27, 10:11PM CDT

Biogen (BIIB) Reports Earnings Tomorrow: What To Expect

BIIB : 193.45 (+1.08%)
BYD
3 Profitable Stocks We Steer Clear Of StockStory - Thu Apr 23, 11:37PM CDT

3 Profitable Stocks We Steer Clear Of

NOC : 549.52 (-0.50%)
BYD : 85.64 (+0.47%)
BIIB : 193.45 (+1.08%)
CDNS
Stocks making big moves yesterday: Cadence Design Systems, JFrog, Lucid, Ulta, and Biogen StockStory - Tue Apr 21, 8:00AM CDT

Stocks making big moves yesterday: Cadence Design Systems, JFrog, Lucid, Ulta, and Biogen

LCID : 6.34 (+4.79%)
ULTA : 521.58 (-0.94%)
FROG : 70.55 (+23.73%)
CDNS : 362.70 (+1.63%)
BIIB : 193.45 (+1.08%)

Barchart Exclusives

Palantir Stock Has a ‘High-Class Problem’: Demand for Its Software Is Far Outpacing Supply Barchart - Sun May 10, 4:00PM CDT
Palantir’s greatest challenge may no longer be demand, but how quickly it can deliver AI software to customers. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.